A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis
Clinical trial NCT06176768 · COMPLETED
Trial details
- NCT number
- NCT06176768
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-06
- Primary completion
- 2025-04-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.